CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
0.8213
+0.0184 (2.29%)
At close: Aug 7, 2026, 4:00 PM EDT
0.8200
-0.0013 (-0.16%)
Pre-market: Aug 10, 2026, 8:37 AM EDT
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $9.72 million as of August 10, 2026. Its market cap has decreased by -54.23% in one year.
Market Cap
9.72M
Enterprise Value
8.46M
1-Year Change
-54.23%
Ranking
Category
Stock Price
$0.82
ChartMarket Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $9.72M, a decrease of -78.93%. That is a compound annual growth rate of -37.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 9.72M | -36.92% |
| Dec 31, 2025 | 15.41M | -60.74% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
| Apr 14, 2023 | 46.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Senti Biosciences Holdings | 11.02M |
| Lunai Bioworks | 10.93M |
| CalciMedica | 10.86M |
| Theriva Biologics | 10.13M |
| Aspire Biopharma Holdings | 10.01M |
| Lisata Therapeutics | 9.65M |
| IN8bio | 9.64M |
| Quoin Pharmaceuticals | 9.62M |